Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Van de Wiele

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Current Drug Discovery Technologies|November 2, 2010
Radioembolization of hepatocellular carcinomaChristophe Van de Wiele
Cancer Biotherapy & Radiopharmaceuticals|June 23, 2009
The immune system and cancerDavid Loose, Christophe Van de Wiele
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2005
Treatment of hepatocellular carcinoma by means of radiopharmaceuticalsBieke Lambert, Christophe Van de Wiele
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2005
The 17th International IRIST Congress ProceedingsChristophe Van de Wiele, Alberto Signore
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Imaging probes targeting matrix metalloproteinasesChristophe Van de Wiele, Ruth Oltenfreiter
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2008
FDG uptake, a surrogate of tumour hypoxia?Rudi Andre Dierckx, Christophe Van de Wiele
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Receptor imaging in oncology by means of nuclear medicine: current statusBieke Van Den Bossche, Christophe Van de Wiele
Seminars in Nuclear Medicine|August 3, 2013
FDG-PET imaging in HIV infection and tuberculosisMike Sathekge, Alex Maes, Christophe Van de Wiele
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Peptide receptor imaging: advances in the diagnosis of pulmonary diseasesChristophe Van de Wiele, Alberto Signore, Rudi Andre Dierckx
Nuclear Medicine Communications|November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next stepAndreas Otte, Christophe van de Wiele, Rudi A Dierckx
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Current Drug Discovery Technologies|November 2, 2010
Radioembolization of hepatocellular carcinomaChristophe Van de Wiele
Cancer Biotherapy & Radiopharmaceuticals|June 23, 2009
The immune system and cancerDavid Loose, Christophe Van de Wiele
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2005
Treatment of hepatocellular carcinoma by means of radiopharmaceuticalsBieke Lambert, Christophe Van de Wiele
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2005
The 17th International IRIST Congress ProceedingsChristophe Van de Wiele, Alberto Signore
Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Imaging probes targeting matrix metalloproteinasesChristophe Van de Wiele, Ruth Oltenfreiter
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2008
FDG uptake, a surrogate of tumour hypoxia?Rudi Andre Dierckx, Christophe Van de Wiele
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2004
Receptor imaging in oncology by means of nuclear medicine: current statusBieke Van Den Bossche, Christophe Van de Wiele
Seminars in Nuclear Medicine|August 3, 2013
FDG-PET imaging in HIV infection and tuberculosisMike Sathekge, Alex Maes, Christophe Van de Wiele
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Peptide receptor imaging: advances in the diagnosis of pulmonary diseasesChristophe Van de Wiele, Alberto Signore, Rudi Andre Dierckx
Nuclear Medicine Communications|November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next stepAndreas Otte, Christophe van de Wiele, Rudi A Dierckx
Pageof 17